IRIS
ZOPPOLI, GABRIELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 15.678
AS - Asia 2.017
NA - Nord America 1.912
Continente sconosciuto - Info sul continente non disponibili 329
SA - Sud America 214
AF - Africa 36
OC - Oceania 5
Totale 20.191
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 15.313
US - Stati Uniti d'America 1.788
SG - Singapore 810
CN - Cina 484
VN - Vietnam 347
BD - Bangladesh 159
FR - Francia 136
BR - Brasile 123
HK - Hong Kong 70
FI - Finlandia 60
AR - Argentina 51
DE - Germania 51
CA - Canada 50
JP - Giappone 26
IN - India 24
MX - Messico 24
GB - Regno Unito 23
IQ - Iraq 21
CH - Svizzera 17
EC - Ecuador 16
NL - Olanda 12
ES - Italia 11
ID - Indonesia 11
PK - Pakistan 9
CR - Costa Rica 8
HN - Honduras 8
JM - Giamaica 8
VE - Venezuela 7
CL - Cile 6
IE - Irlanda 6
UZ - Uzbekistan 6
ZA - Sudafrica 6
GT - Guatemala 5
LT - Lituania 5
MA - Marocco 5
PH - Filippine 5
RU - Federazione Russa 5
SE - Svezia 5
TR - Turchia 5
UA - Ucraina 5
AU - Australia 4
CO - Colombia 4
DZ - Algeria 4
EG - Egitto 4
NP - Nepal 4
PA - Panama 4
PL - Polonia 4
TH - Thailandia 4
TT - Trinidad e Tobago 4
TW - Taiwan 4
AL - Albania 3
BG - Bulgaria 3
KE - Kenya 3
PR - Porto Rico 3
SA - Arabia Saudita 3
TN - Tunisia 3
UY - Uruguay 3
AZ - Azerbaigian 2
BE - Belgio 2
CG - Congo 2
GR - Grecia 2
JO - Giordania 2
KG - Kirghizistan 2
KR - Corea 2
MM - Myanmar 2
MT - Malta 2
NI - Nicaragua 2
PE - Perù 2
PT - Portogallo 2
PY - Paraguay 2
SI - Slovenia 2
SN - Senegal 2
SV - El Salvador 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AT - Austria 1
BB - Barbados 1
BS - Bahamas 1
BY - Bielorussia 1
BZ - Belize 1
CV - Capo Verde 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GA - Gabon 1
GE - Georgia 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
IR - Iran 1
KH - Cambogia 1
KW - Kuwait 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LC - Santa Lucia 1
LV - Lettonia 1
MD - Moldavia 1
Totale 19.851
Salva come PNG Salva come JPEG
Città #
Genova 7.149
Genoa 5.460
Rapallo 1.330
Vado Ligure 1.037
San Jose 428
Singapore 382
Ashburn 269
Lauterbourg 117
Ho Chi Minh City 107
Beijing 96
Council Bluffs 90
Milan 75
Hanoi 69
New York 67
Hong Kong 63
Los Angeles 52
Helsinki 51
Frankfurt am Main 43
Bordighera 36
Santa Clara 33
Chicago 22
Haiphong 22
Buffalo 20
Rome 20
Boardman 18
Tokyo 18
Orem 16
São Paulo 16
Dallas 14
Valenza 14
Zurich 13
Da Nang 11
Houston 11
Mexico City 11
Montreal 11
Tianjin 11
Paris 10
Phoenix 10
Atlanta 9
Biên Hòa 9
Lappeenranta 9
Des Moines 8
Miami 8
Seattle 8
Toronto 8
City of London 7
Naples 7
San José 7
Baghdad 6
Can Tho 6
Cardiff 6
Johannesburg 6
Philadelphia 6
Piscataway 6
Rio de Janeiro 6
Shenzhen 6
The Bronx 6
Washington 6
Amsterdam 5
Baltimore 5
Bari 5
Bologna 5
Buenos Aires 5
Catania 5
Dublin 5
Fresno 5
Guangzhou 5
Kingston 5
Lansdowne 5
London 5
Milwaukee 5
Newark 5
Ottawa 5
Reseda 5
Stockholm 5
Tashkent 5
Bắc Ninh 4
Cagliari 4
Chennai 4
Durham 4
Guayaquil 4
Hải Dương 4
Jacksonville 4
Madrid 4
Marseille 4
Minneapolis 4
Panama City 4
Phủ Lý 4
Porto Alegre 4
Rovereto 4
Santiago 4
Warsaw 4
Basra 3
Birmingham 3
Boydton 3
Charlotte 3
Columbus 3
Concordia 3
Denver 3
Dhaka 3
Totale 17.540
Salva come PNG Salva come JPEG
Nome #
A modular framework for the development of targeted Covid-19 blood transcript profiling panels 347
Advances in dynamic modeling of colorectal cancer signaling-network regions, a path toward targeted therapies. 279
1222 POSTER Chemical Screening for Potentiators of Lapatinib Activity in Human Breast Cancer 262
APO866 activity in hematologic malignancies: a preclinical in vitro study. 252
Grb7 upregulation is a molecular adaptation to HER2 signaling inhibition due to removal of AKT-mediated gene repression 252
P-334 * Radiological assessments for select patients in neoadjuvant setting in rectal cancer: monoinstitutional experience 250
1221 POSTER Chemical-genetic Screenings for Synthetic-lethal Interactions in Breast Cancer 248
DNA aneuploidy relationship with patient age and tobacco smoke in OPMDs/OSCCs 229
A novel Bim-BH3-derived Bcl-X(L) inhibitor: Biochemical characterization, in vitro, in vivo and ex-vivo anti-leukemic activity 226
Catastrophic NAD(+) Depletion in Activated T Lymphocytes through Nampt Inhibition Reduces Demyelination and Disability in EAE 226
Impaired response to influenza vaccine associated with persistent memory B cell depletion in non-Hodgkin's lymphoma patients treated with rituximab-containing regimens. 219
Systems medicine in colorectal cancer: from a mathematical model toward a new type of clinical trial 218
Uncovering the genomic heterogeneity of multifocal breast cancer 214
Lymph node number, surface area and lymph node ratio are important prognostic indicators in neoadjuvant chemoradiotherapy treated rectal cancer 212
Ataxia-Telangiectasia Mutated Loss of Heterozygosity in Melanoma 209
Abstract 49: Agreement of immunohistochemistry, fluorescence in situ hybridization, real-time quantitative polymerase-chain reaction, and quantitative reverse transcriptase PCR for Her-2/Neu status assessment in breast cancer patients: a single center, retrospective m 208
Nicotinamide phosphoribosyltransferase promotes epithelial-to-mesenchymal transition as a soluble factor independent of its enzymatic activity. 207
Genomic DNA copy number aberrations, histological diagnosis, oral subsite and aneuploidy in OPMDs/OSCCs 207
Ras-induced resistance to lapatinib is overcome by MEK inhibition 205
Role of angiogenesis inhibitors in colorectal cancer: sensitive and insensitive tumors. 203
ANTITUMOR ACTIVITY OF NAMPT INHIBITION AND SYNERGY WITH CYCLOSPORIN A AND HDACIS TO PROMOTE APOPTOSIS IN PRIMARY LEUKEMIC CELLS 199
Synergistic interactions between HDAC and sirtuin inhibitors in human leukemia cells. 191
Patient-tailored treatments with anti-EGFR monoclonal antibodies in advanced colorectal cancer: KRAS and beyond. 190
Schlafen 11 Assessment in High-Grade Serous Ovarian Carcinoma: Phenotypic and Histological Distribution 190
Circulating tumor DNA using tagged targeted deep sequencing to assess minimal residual disease in breast cancer patients undergoing neoadjuvant chemotherapy 190
Squalene epoxidase as a promising metabolic target in cancer treatment 189
Clinico-pathological associations and concomitant mutations of the RAS/RAF pathway in metastatic colorectal cancer 189
Abstract 986: Unraveling breast cancer progression through geographical and temporal sequencing 188
The association between adiposity and anti-proliferative response to neoadjuvant endocrine therapy with letrozole in post-menopausal patients with estrogen receptor positive breast cancer 187
Abstract A120: Cellular inhibition of Chk2 kinase and potentiation of camptothecins and radiation by the novel Chk2 inhibitor PV1019 185
Dynamic simulations of pathways downstream of TGF-beta , Wnt and EGF-family growth factors, in colorectal cancer, including mutations and treatments with onco-protein inhibitors 183
Systems medicine in oncology: Signaling network modeling and new-generation decision-support systems 181
Chemical-genetic Screenings for Synthetic-lethal Interactions in Breast Cancer 180
Her2 assessment using quantitative reverse transcriptase polymerase chain reaction reliably identifies Her2 overexpression without amplification in breast cancer cases 180
Identification and Management of Immune Checkpoint Inhibitor-Related Myocarditis: Use Troponin Wisely 180
Synergistic interactions between HDAC and sirtuin inhibitors in human leukemia cells 179
Development of a hoRizontal data intEgration classifier for NOn-invasive early diAgnosis of breasT cancEr: the RENOVATE study protocol 176
Squalene epoxidase is a bona fide oncogene by amplification with clinical relevance in breast cancer 175
Apoptosis of B-cell chronic lymphocytic leukemia cells induced by a novel BH3 peptidomimetic 175
Seasonal and pandemic (A/H1N1 2009) MF-59-adjuvanted influenza vaccines in complete remission non-Hodgkin lymphoma patients previously treated with rituximab containing regimens. 174
Abstract 4693: The putative DNA/RNA Helicase Schlafen-11 sensitizes cancer cells to topoisomerase I inhibitors 174
Incidence and immunomic features of apyretic COVID-19 in patients affected by solid tumors: a prospective cohort study 173
Quantitative Real Time PCR assessment of hormonal receptors and HER2 status on fine-needle aspiration pre-operatory specimens from a prospectively accrued cohort of women with suspect breast malignant lesions. 172
Report on the first SLFN11 monothematic workshop: from function to role as a biomarker in cancer 170
The role of sentinel lymph node biopsy in patients with B5C breast cancer diagnosis 170
The effect of preoperative chemoradiotherapy on lymph nodes harvested in TME for rectal cancer. 169
Abstract CT075: Fasting-mimicking diet and hormone therapy modulates metabolic factors to promote breast cancer regression and reduce side effects 168
Potent synergistic interaction between the Nampt inhibitor APO866 and the apoptosis activator TRAIL in human leukemia cells. 163
Correction to: Schlafen-11 expression is associated with immune signatures and basal-like phenotype in breast cancer (Breast Cancer Research and Treatment, (2019), 10.1007/s10549-019-05313-w) 162
Putative DNA/RNA helicase Schlafen-11 (SLFN11) sensitizes cancer cells to DNA-damaging agents 160
Abstract S2-05: Characterization and clinical relevance of the genomic alterations defining lobular breast cancer: 159
Polycythemia as rare secondary direct manifestation of acromegaly: management and single-centre epidemiological data. 158
Gene expression profiling in acute allograft rejection: challenging the immunologic constant of rejection hypothesis. 157
Abstract 2116:CHEK2(Chk2) endogenous activation is associated with p53 deficiency and downregulation ofBRCA2and Fanconi Anemia pathway gene members in the National Cancer Institute Anticancer Tumor Cell Line Panel (NCI-60) 156
Genomic Characterization of Primary Invasive Lobular Breast Cancer 155
HDAC INHIBITORS SYNERGISTICALLY ENHANCE AP0866 ACTIVITY IN HUMAN LEUKEMIA CELLS: EVIDENCE FOR CONVERGING MECHANISMS OF SIRT1 INHIBITION 154
Patients Treated with Rituximab-Containing Immunochemotherapy Have a Significant and Prolonged Lack of Humoral Response to Influenza Vaccine Associated with a Persistent Depletion of B Memory Cells 153
Development of a predictor of one-year mortality in older patients with cancer by geriatric and oncologic parameters 153
Schlafen-11 expression is associated with immune signatures and basal-like phenotype in breast cancer 152
DNA damage response pathways and cell cycle checkpoints in colorectal cancer: current concepts and future perspectives for targeted treatment. 151
Chemical Screening for Potentiators of Lapatinib Activity in Human Breast Cancer 151
Safety and feasibility of fasting‐mimicking diet and effects on nutritional status and circulating metabolic and inflammatory factors in cancer patients undergoing active treatment 151
Sequential dose-dense 5-fluorouracil, epirubicin and cyclophosphamide followed by docetaxel in patients with early breast cancer with four or more positive lymph nodes. 150
Relevance of HBV/HBcAb screening in lymphoma patients treated in the Rituximab era 149
OMEGA (Offline Mutation Easy Genetic Annotator), a software analysis pipeline designed for thorough and easy annotation of NGS output 148
Low percentage of KRAS mutations revealed by locked nucleic acid polymerase chain reaction: implications for treatment of metastatic colorectal cancer. 145
Transcriptomic and genomic features of invasive lobular breast cancer 144
Monotherapy with Pegylated Interferon Alpha-2a in Hemodialyzed Patients with Chronic Hepatitis C 142
CHEK2 genomic and proteomic analyses reveal genetic inactivation or endogenous activation across the 60 cell lines of the US National Cancer Institute. 142
Identification of a predominant co-regulation among kinetochore genes, prospective regulatory elements, and association with genomic instability. 141
The NAD+-dependent histone deacetylase SIRT6 promotes cytokine production and migration in pancreatic cancer cells by regulating Ca2+ responses. 141
Development of a long non-coding RNA signature for prediction of response to neoadjuvant chemoradiotherapy in locally advanced rectal adenocarcinoma 141
Longer intervals after neoadjuvant therapy in locally advanced rectal cancer: a monocentric experience 139
Biological modifications of the immune response to COVID-19 vaccine in patients treated with rituximab and immune checkpoint inhibitors 138
Coordinated regulation of mitochondrial topoisomerase IB with mitochondrial nuclear encoded genes and MYC. 138
Plasma Cell-Free DNA Integrity Assessed by Automated Electrophoresis Predicts the Achievement of Pathologic Complete Response to Neoadjuvant Chemotherapy in Patients with Breast Cancer 138
Genomic aberrations in young and elderly breast cancer patients 136
Impaired Humoral Response to Influenza Vaccine and Prolonged B Memory Cell Depletion as a Consequence of Rituximab-based Immunochemotherapy in non-Hodgkin Lymphoma Patients 135
Immune Infiltration in Invasive Lobular Breast Cancer 134
Pre-operative and pathologic assessment in neoadjuvant setting for rectal cancer: the experience of "RECOM Group". 132
Tumor-to-nipple Distance Should Not Preclude Nipple-sparing Mastectomy in Breast Cancer Patients. Personal Experience and Literature Review 132
Gynaecomastia: the anastrozole paradox 131
Depletion of the intracellular coenzyme NAD plus in activated T-cells ameliorates experimental autoimmune encephalomyelitis 130
Breast Cancer Surgery in the COVID-19 Pandemic: Validation of a Preventive Program for Patients and Health Care Workers 128
An integrated tumor, immune and microbiome atlas of colon cancer 125
Clinical and Radiological Predictors of Biochemical Response to First-Line Treatment With Somatostatin Receptor Ligands in Acromegaly: A Real-Life Perspective 125
Mutational analysis of BRCA1 and BRCA2 genes in high grade serous ovarian carcinoma with Next Generation Sequencing (NGS); correlation between somatic and germline mutations 124
Transcriptome Sequencing Of The Transition From Normal Epithelium To Invasive Cancer Reveals Insights Into The Carcinogenesis Of Hpv+ And Hpv- Vulvar Neoplasia 123
On biomarkers and pathways in rectal cancer: What's the target? 121
Paralytic ileus and liver failure-an unusual presentation of advanced erythropoietic protoporphyria 121
70-gene signature as an aid for treatment decisions in early breast cancer: updated results of the phase 3 randomised MINDACT trial with an exploratory analysis by age 120
Weekly standard doses of rh-EPO are highly effective for the treatment of anemic patients with low-intermediate 1 risk myelodysplastic syndromes. 118
Assessment of circulating nucleic acids in cancer: From current status to future perspectives and potential clinical applications 118
High-temporal resolution profiling reveals distinct immune trajectories following the first and second doses of COVID-19 mRNA vaccines 116
Potent Synergistic Activity of the NAD plus Synthesis Inhibitor APO866 and of the Apoptosis Inducer TRAIL in in Vitro and Ex Vivo Cellular Models of Non Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia. 116
Prospective validation study of prognostic biomarkers to predict adverse outcomes in patients with COVID-19: A study protocol 116
Whole-Exome Sequencing and cfDNA Analysis Uncover Genetic Determinants of Melanoma Therapy Response in a Real-World Setting 115
Standard Operating Procedures (SOPs) for non-invasive multiple biomarkers detection in an academic setting: a critical review of the literature for the RENOVATE study protocol 115
Complete pathological response of hormone receptor positive invasive breast cancer in a patient with multiple myeloma treated with ixazomib 113
Standard Anthracycline-based versus Docetaxel-Capecitabine in early high clinical and/or genomic risk breast cancer in the EORTC 10041/ BIG 3-04 MINDACT phase III trial 110
Totale 16.835
Salva come PNG Salva come JPEG
Categoria #
all - tutte 64.768
article - articoli 62.582
book - libri 0
conference - conferenze 1.124
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.062
Totale 129.536
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.393 62 75 110 177 72 91 71 302 80 132 71 150
2022/20231.632 161 165 13 181 257 208 26 131 253 7 206 24
2023/20241.050 42 123 24 126 96 198 44 84 53 35 70 155
2024/20253.226 139 173 74 204 305 306 283 528 94 119 450 551
2025/20266.430 657 266 743 553 773 419 860 315 488 631 356 369
2026/2027508 508 0 0 0 0 0 0 0 0 0 0 0
Totale 20.191